0001209191-15-074449.txt : 20151006
0001209191-15-074449.hdr.sgml : 20151006
20151006211109
ACCESSION NUMBER: 0001209191-15-074449
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151002
FILED AS OF DATE: 20151006
DATE AS OF CHANGE: 20151006
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001394319
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8910 UNIVERSITY CENTER DRIVE
STREET 2: SUITE 700
CITY: San Diego
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-550-0780
MAIL ADDRESS:
STREET 1: 8910 UNIVERSITY CENTER DRIVE
STREET 2: SUITE 700
CITY: San Diego
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JAFCO Super V3 Investment Limited Partnership
CENTRAL INDEX KEY: 0001590442
STATE OF INCORPORATION: M0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36818
FILM NUMBER: 151147622
BUSINESS ADDRESS:
STREET 1: OTEMACHI FIRST SQUARE, WEST TOWER 11F
STREET 2: 1-5-1 OTEMACHI
CITY: CHIYODA-KU, TOKYO 100-0004
STATE: M0
ZIP: 100-0004
BUSINESS PHONE: 81-3-5223-7008
MAIL ADDRESS:
STREET 1: OTEMACHI FIRST SQUARE, WEST TOWER 11F
STREET 2: 1-5-1 OTEMACHI
CITY: CHIYODA-KU, TOKYO 100-0004
STATE: M0
ZIP: 100-0004
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-10-02
0
0001394319
Tracon Pharmaceuticals, Inc.
TCON
0001590442
JAFCO Super V3 Investment Limited Partnership
OTEMACHI FIRST SQUARE, WEST TOWER 11F
1-5-1 OTEMACHI, CHIYODA-KU
TOKYO
M0
100-0004
JAPAN
0
0
1
0
Common Stock
2015-10-02
4
S
0
6300
10.0644
D
1537741
D
Common Stock
2015-10-05
4
S
0
8800
10.0966
D
1528941
D
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.00 to $10.20. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $10.00 to $10.205. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
/s/ Kenji Harada
2015-10-06